InSite Vision Inc. (fka INSV)

[stocktrademan]

$INSV recent news/filings

bullish
threre is a bidding contest between parties to buyout fhe company

Mystery, intrigue as biotech M&A explodes
http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/09/biotech-mergers-acquisitions-insv-qlti-depo-hznp.html

## source: finance.yahoo.com

Sat, 05 Sep 2015 01:16:13 GMT ~ QLT Provides Additional Update on Its Proposed Acquisition of InSite Vision Incorporated

[at noodls] - VANCOUVER, British Columbia, Sept. 4, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ('QLT' or the 'Company') announces that it has been advised by InSite Vision Incorporated ('InSite') that ...

read full: http://www.noodls.com/view/F9D33D0615D6E0C3E72D399997439296C6CA8638
*********************************************************

Fri, 04 Sep 2015 22:16:14 GMT ~ InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”

[at noodls] - InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a 'Company Superior Proposal' Bidder Favorably Concludes ...

read full: http://www.noodls.com/view/3F5E9325E5FFC509C01F163E93C68A302010A702
*********************************************************

Fri, 04 Sep 2015 22:15:03 GMT ~ Mystery, intrigue as biotech M&A explodes


read full: http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/09/biotech-mergers-acquisitions-insv-qlti-depo-hznp.html?ana=yahoo
*********************************************************

Fri, 04 Sep 2015 21:49:00 GMT ~ InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”

[Business Wire] - InSite Vision Inc. today announced that InSite’s Board of Directors has determined that the previously announced unsolicited offer from a global pharmaceutical company to acquire all outstanding shares of InSite Vision common stock at $0.35 per share in an all-cash transaction constitutes a “Company Superior Proposal” as defined in InSite’s previously announced definitive agreement with QLT Inc.

read full: http://finance.yahoo.com/news/insite-vision-determines-unsolicited-offer-214900847.html
*********************************************************

Fri, 04 Sep 2015 21:20:32 GMT ~ INSITE VISION INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/150904/insv8-k.html
*********************************************************

$INSV charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$INSV company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/INSV/company-info
Ticker: $INSV
OTC Market Place: OTCQB
CIK code: 0000802724
Company name: InSite Vision, Inc.
Company website: http://www.insitevision.com
Incorporated In: DE, USA

Business Description: InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs. The Company's lead product is AzaSite*, which targets infections of the eye. AzaSite contains the drug azithromycin, a broad-spectrum antibiotic formulated with DuraSite, InSite Vision's patented drug-delivery vehicle, which offers the benefit of a low-dosing regimen, attractive to both the eye-care patient and physician.AzaSite was launched in the United States in August 2007 by Inspire Pharmaceuticals, InSite Vision's commercial partner for the U.S. and Canada. The company's product development portfolio also includes ISV-502 (AzaSite Plus), which is currently in Phase 3 pivotal trials for the treatment of eyelid infection and inflammation, and additional product candidates leveraging the company's core DuraSite technology platform. InSite has recently advanced two new product candidates for the treatment of eye pain and inflammation into preclinical testing.InSite Vision's strategy includes maximizing AzaSite sales in the U.S. and abroad through close collaboration with marketing partners, seeking development partners for its DuraSite-enabled early-stage product candidates, and applying the company's expertise in ophthalmology to identify, in-license, or acquire promising new product candidates or technologies.Less >>

$INSV share structure

## source: otcmarkets.com

Market Value: $44,203,596 a/o Sep 04, 2015
Shares Outstanding: 131,951,033 a/o Feb 24, 2015
Float: Not Available
Authorized Shares: 240,000,000 a/o Feb 12, 2015
Par Value: 0.01

$INSV extra dd links

Company name: InSite Vision, Inc.
Company website: http://www.insitevision.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/INSV/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/INSV/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=INSV+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=INSV+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=INSV+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/INSV/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/INSV/news - http://finance.yahoo.com/q/h?s=INSV+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/INSV/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/INSV/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/INSV/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/INSV/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/INSV/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/INSV/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/INSV/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/INSV/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=INSV+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/INSV
DTCC (dtcc.com): http://search2.dtcc.com/?q=InSite+Vision%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=InSite+Vision%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=InSite+Vision%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.insitevision.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.insitevision.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.insitevision.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/INSV/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/INSV
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/INSV/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/INSV/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/INSV/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000802724&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/INSV/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/INSV/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/INSV/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/INSV/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=INSV&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=INSV
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/INSV/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=INSV+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=INSV+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=INSV
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=INSV
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=INSV+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/INSV/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=INSV+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/INSV.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=INSV
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/INSV/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/INSV/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/INSV/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/INSV/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/INSV
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/INSV
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/INSV:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=INSV
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=INSV



$INSV DD Notes ~ http://www.ddnotesmaker.com/INSV